Nordic Life Science Awards

Get the presentations from the selected finalists and applause the winners

Nordic Life Science Awards

16:30 - 19:00 Exhibition Area - NLSDays Arena

This year we inaugurate the new Nordic Life Science Awards competition.

The Nordic Life Science Awards will be given to one academic research group project (“Academic Class”) with a break-through potential and to one life science-company (“Business Class”) considered by the jury to best meet the award criteria presented in this document. A second company (“Delegates Choice”) will be selected by popular vote.

The Jury consists of:

  • Dr. Sara Gunnerås, Director Business & Finance, SwedenBIO (Chair)
  • Dr. Ulrica Sehlstedt, Partner, Arthur D. Little
  • Ms. Sophie Labrosse, Cluster Officer at Novo Nordisk Foundation
  • Dr. Christos Vaitsis, Business Creation Manager at EIT Health Scandinavia
  • Ms. Erna Björnsdóttir, Manager, Invest in Iceland at Promote Iceland

Part 1 – Nordic Life Science Academic Class Award

 “Advancing academic ideas into innovations for patients” 

Academia is a key engine for medical innovation and many life science projects becoming commercial successful originate from academic centers. Big ideas very often come from ground-braking academic research. Recognizing that the majority of the global companies made academic-industrial partnerships an integral part of their strategies and opened their R&D organizations to external innovation. 

The Academic Catwalk features exciting academic projects from five Nordic countries illustrating the rich and broad research milieus and their motivation to advance their ideas into innovations for patients. The session is hosted by SPARK Norway and delivered in collaboration with SPARK Finland, the Swedish SciLifeLabs, the Danish BioInnovation Institute, Promote Iceland and sponsored by Arthur D. Little and EIT Health Scandinavia.

 SciLifeLab Sweden 

  • “Improving the drugability of neoantigens in immuno-oncology”, Sara Mangsbo, Uppsala University 
  • “MTHFD2 as new DDR strategy for targeting cancer by synthetic lethality”, Thomas Helleday, Karolinska Institute 
 SPARK Norway, UiO:Life Science at the University of Oslo 

  • “A biologic therapeutic for pulmonary fibrosis”, Ole Jørgen Kaasbøll, University of Oslo, SPARK Norway 
  • “Novel treatment for heart failure”, Henriette Andresen, Univ. of Oslo, SPARK Norway
 SPARK Finland 

  • “Nextcast, AI solution for chemical and drug toxicity testing”, Troy Faithfull, SPARK Finland 
  • “A novel Parkinson’s signature biomarker assay”, Patrik Hollos, SPARK Finland 
 BioInnovation Institute Denmark 

  • “A new drug for treatment-resistant depression”, Emil Märcher-Rørsted, University of Copenhagen 
  • “Novel detoxification technology turning bacterial toxins into vaccines antigens”; Kaper Gubba Ørtenblad, Statens Serum Institute 
 Iceland 

  • ”Placental protein 13 used to prevent preeclampsia”, Sveinbjörn Gizurarson, University of Iceland 

More details here

 

Part 2 – Nordic Life Science Business Class and Delegates Choice Awards

Nordic life science companies are well known and respected for their strong science-base and a long history of bringing innovation to the market. The company session will feature two companies from each of the Nordic countries. The winner of the “Business Class Award” show scientific excellence and run projects that have a break-through possibility or have already made it to the market adding significant value to patients. For the “Delegates Choice Award”: the audience will be asked to vote for the company they are most likely to invest in should they be given the opportunity. The session is hosted by SwedenBIO, Oslo Cancer Cluster, Turku Science Park, the Danish BioInnovation Institute and sponsored by Arthur D. Little and EIT Health Scandinavia.

Moderator:

Ms. Sarah Lidé, Senior strategy and project manager, Medicon Valley Alliance

Akthelia (Iceland) A novel antimicrobial platform

Cirqle (Denmark) Focused on developing innovative contraceptives

Delsitech (Finland) New nanotech solutions in drug delivery

Elypta (Sweden) Metabolic biomarkers and AI to detect cancer

EpiEndo (Iceland) Focused on novel solutions for chronic airway diseases

Saromics (Sweden) Protein crystallography and drug discovery services

Synklino (Denmark) Eradicating cytomegalovirus infections

TBA (Norway)

Hosted by:

Spark Norway

Spark Norway

Spark Finland

Spark Finland

SciLifeLab

SciLifeLab

BioInnovation Institute

BioInnovation Institute

UiO: University of Oslo

UiO: University of Oslo

Oslo Cancer Cluster

Oslo Cancer Cluster

The Life Science Cluster

The Life Science Cluster

Health Turku

Health Turku

Promote Iceland

Promote Iceland

Sponsored by:

Arthur D. Little

Arthur D. Little

EIT Health

EIT Health

full program